Gubra A/S

GUBRA

Equity

ISIN DK0062266474 / Valor 125706804

Nasdaq Copenhagen Equities (2025-12-19)

DKK 517.50+3.50%

Gubra A/S
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Gubra A/S is a specialized company focusing on high-end preclinical contract research and peptide-based drug discovery, particularly within the realms of metabolic and fibrotic diseases. Utilizing advanced models and technologies, Gubra provides rapid and high-quality data through its comprehensive services. The company’s light-sheet microscopy platform enables 3D imaging of organs in mice and rats, while its automated imaging pipeline and AI-driven image analysis ensure precise drug distribution mapping and histological quantification. Gubra offers a range of histology services, including core histology, multiplex immunohistochemistry, RNAScope®, and unbiased stereology analysis. Additionally, the company provides specialized models for cardiovascular diseases, such as hypertension-induced heart failure and atherosclerosis, complemented by state-of-the-art echocardiography and quantitative whole-heart 3D histology. Gubra also excels in peptide drug discovery, leveraging its AI-driven streaMLine platform to develop clinical-ready drug candidates with robust intellectual property protection. The company’s expertise spans linear, cyclic, disulfide-rich peptides, and peptide drug-conjugates, facilitating the transition from target identification to in vivo target validation.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-26.9%1Y

%3Y

%5Y

Performance

73.4%1Y

67.3%3Y

67.3%5Y

Volatility